Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2007
A randomized, double-masked, placebo-controlled study of alicaforsen, an antisense inhibitor of intercellular adhesion molecule 1, for the treatment of subjects with active Crohn's diseaseBruce Yacyshyn, William Y Chey, Mark K Wedel, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|November 28, 2023
Repurposing dried blood spot device technology to examine bile acid profiles in human dried fecal spot samplesMelinda A Engevik, Santosh Thapa, Ian M Lillie, et al.Gastroenterology|September 22, 2009
Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitisWilliam J Sandborn, Jaroslaw Regula, Brian G Feagan, et al.Gastroenterology|November 13, 2019
Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative ColitisWilliam J Sandborn, Laurent Peyrin-Biroulet, Jinkun Zhang, et al.Journal of Pediatric Gastroenterology and Nutrition|November 25, 2014
High- and low-dose oral delayed-release mesalamine in children with mild-to-moderately active ulcerative colitisHarland S Winter, Piotr Krzeski, Melvin B Heyman, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|March 31, 2018
Clostridium difficile toxins A and B decrease intestinal SLC26A3 protein expressionHayley Coffing, Shubha Priyamvada, Arivarasu N Anbazhagan, et al.Journal of Pediatric Psychology|November 25, 2020
Transition to Adult IBD Care: A Pilot Multi-Site, Telehealth Hybrid InterventionWendy N Gray, Scott T Wagoner, Megan R Schaefer, et al.The Lancet. Infectious Diseases|May 3, 2017
Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority studyRichard J Vickers, Glenn S Tillotson, Richard Nathan, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2018
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for RecurrenceDale N Gerding, Ciaran P Kelly, Galia Rahav, et al.Cell Reports|March 16, 2017
Canonical Wnt Signaling Ameliorates Aging of Intestinal Stem CellsKodandaramireddy Nalapareddy, Kalpana J Nattamai, Rupali S Kumar, et al.Pageof 2